4//SEC Filing
de Verneuil Vanina 4
Accession 0001628280-24-049897
CIK 0001706431other
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 3:35 PM ET
Size
5.2 KB
Accession
0001628280-24-049897
Insider Transaction Report
Form 4
de Verneuil Vanina
EVP and General Counsel
Transactions
- Sale
Common Stock
2024-12-02$8.22/sh−76$625→ 56,973 total
Footnotes (2)
- [F1]The shares were sold pursuant to a sale instruction entered into on May 28, 2024, whereby shares purchased on November 29, 2024 pursuant to the Issuer's employee stock purchase program were automatically sold six months after the instruction date.
- [F2]Reflects ownership after acquisition by the reporting person on November 29, 2024 of 76 shares of common stock pursuant to the Issuer's employee stock purchase program, and sale of such shares on December 2, 2024.
Documents
Issuer
Vir Biotechnology, Inc.
CIK 0001706431
Entity typeother
Related Parties
1- filerCIK 0002036234
Filing Metadata
- Form type
- 4
- Filed
- Dec 3, 7:00 PM ET
- Accepted
- Dec 4, 3:35 PM ET
- Size
- 5.2 KB